These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Association of L-tryptophan and an illness resembling eosinophilic fasciitis. Clinical and histopathologic findings in four patients with eosinophilia-myalgia syndrome. Bulpitt KJ; Verity MA; Clements PJ; Paulus HE Arthritis Rheum; 1990 Jul; 33(7):918-29. PubMed ID: 2369428 [TBL] [Abstract][Full Text] [Related]
6. Scleroderma, fasciitis, and eosinophilia associated with the ingestion of tryptophan. Silver RM; Heyes MP; Maize JC; Quearry B; Vionnet-Fuasset M; Sternberg EM N Engl J Med; 1990 Mar; 322(13):874-81. PubMed ID: 1690352 [TBL] [Abstract][Full Text] [Related]
7. Idiopathic and L-tryptophan-associated eosinophilic fasciitis before and after L-tryptophan contamination. Blauvelt A; Falanga V Arch Dermatol; 1991 Aug; 127(8):1159-66. PubMed ID: 1863073 [TBL] [Abstract][Full Text] [Related]
8. Histopathologic features of the L-tryptophan-related eosinophilia-myalgia (fasciitis) syndrome. Winkelmann RK; Connolly SM; Quimby SR; Griffing WL; Lie JT Mayo Clin Proc; 1991 May; 66(5):457-63. PubMed ID: 1709432 [TBL] [Abstract][Full Text] [Related]
9. L-tryptophan ingestion associated with eosinophilic fasciitis but not progressive systemic sclerosis. Freundlich B; Werth VP; Rook AH; O'Connor CR; Schumacher HR; Leyden JJ; Stolley PD Ann Intern Med; 1990 May; 112(10):758-62. PubMed ID: 2331120 [TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of patients with diffuse fasciitis and eosinophilia associated with L-tryptophan ingestion. Beko E; Pervaiz S; Nanda V; Dhawan S Cutis; 1993 Apr; 51(4):266-70. PubMed ID: 8477608 [TBL] [Abstract][Full Text] [Related]
11. An eosinophilia-myalgia syndrome associated with an L-tryptophan containing product. Saag KG; Goldschmidt R; Vernof H; Golbus J J Rheumatol; 1990 Nov; 17(11):1551-3. PubMed ID: 2273501 [TBL] [Abstract][Full Text] [Related]
12. Microangiopathy in the eosinophilia-myalgia syndrome. Smith SA; Roelofs RI; Gertner E J Rheumatol; 1990 Nov; 17(11):1544-50. PubMed ID: 2273500 [TBL] [Abstract][Full Text] [Related]
13. Neuromuscular manifestations of L-tryptophan-associated eosinophilia-myalgia syndrome: a histomorphologic analysis of 14 patients. Verity MA; Bulpitt KJ; Paulus HE Hum Pathol; 1991 Jan; 22(1):3-11. PubMed ID: 1985074 [TBL] [Abstract][Full Text] [Related]
14. Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan. Hertzman PA; Blevins WL; Mayer J; Greenfield B; Ting M; Gleich GJ N Engl J Med; 1990 Mar; 322(13):869-73. PubMed ID: 2314421 [TBL] [Abstract][Full Text] [Related]
15. Perimyositis with perineuritis and myofiber type grouping in the eosinophilia myalgia syndrome associated with tryptophan ingestion. Talpos DC; Carstens SA; Silverman J; Gladson CL Am J Surg Pathol; 1991 Mar; 15(3):222-6. PubMed ID: 1996728 [TBL] [Abstract][Full Text] [Related]
16. L-tryptophan-associated eosinophilia-myalgia syndrome: perspective of a new illness. Kaufman LD; Seidman RJ Rheum Dis Clin North Am; 1991 May; 17(2):427-41. PubMed ID: 1862249 [TBL] [Abstract][Full Text] [Related]
17. The clinical spectrum of the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Clinical features in 20 patients and aspects of pathophysiology. Martin RW; Duffy J; Engel AG; Lie JT; Bowles CA; Moyer TP; Gleich GJ Ann Intern Med; 1990 Jul; 113(2):124-34. PubMed ID: 2360751 [TBL] [Abstract][Full Text] [Related]